In fact, various studies have demonstrated that exogenous IGF-1 has the ability to induce muscle hypertrophy and may have therapeutic value in treating muscle degenerative diseases, sarcopenia, disuse-mediated skeletal muscle atrophy and bone osteopenia [39]–[43], although the actual effectiveness is still controversial [44], [45]. Here, IGF1 is linked to sarcopenia.